Articles

Results 1 to 5 of 8
Most popular |Most recent


In brief: anticompetitive agreements in the pharmaceutical sector in United Kingdom

United Kingdom - June 30 2020 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in United Kingdom, including the assessment framework and special issues with vertical agreements.

Alec Burnside, Michael I. Okkonen, Robert Darwin.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in United Kingdom

United Kingdom - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in United Kingdom, including IP rights abuse and pricing conduct.

Alec Burnside, Michael I. Okkonen, Robert Darwin.

At a glance: pharmaceutical merger review in United Kingdom

United Kingdom - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in United Kingdom, including review triggers and thresholds.

Alec Burnside, Michael I. Okkonen, Robert Darwin.

Pharmaceutical antitrust law in United Kingdom

United Kingdom - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in United Kingdom, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance.

Alec Burnside, Michael I. Okkonen.

Anticompetitive unilateral conduct in the pharmaceutical sector in United Kingdom

United Kingdom - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in United Kingdom, including IP rights abuse and pricing conduct.

Alec Burnside, Michael I. Okkonen.